DOI: http://dx.doi.org/10.18203/2349-3933.ijam20173243

Assessment of IBS symptoms among patients of lower socio-economic strata attending medicine OPD in a tertiary care hospital in South Delhi

Sana Rehman, Anwar Habib, Razi Ahmad, Zenis Baluja

Abstract


Background: Irritable bowel syndrome (IBS) is a common functional disorder throughout the world with no clear diagnostic markers. The diagnosis relies mostly on clinical presentation. In India, IBS is less estimated in lower socioeconomic group population. The objective of this study was to assess the proportions of symptoms compatible with IBS, and its prevalence among the patients of low socio-economic strata.

Methods: An OPD based observational study carried out in a tertiary care hospital in south Delhi for a period of 10 years (Nov-2006 to Oct-2016). This hospital caters to low socioeconomic strata. All the study subjects were interviewed based on questionnaires compatible with Manning and Rome II criteria

Results: Symptoms of IBS was more in male (65.12%) and highest prevalence was in the age group 31 to 35 years (56.62%), flatulence was found to be the most common symptom compatible with IBS (58.37%) followed by pain abdomen (42.9%), loose motion (38.6%) and constipation (30.5%). The other important associated symptoms were headache 47.7% and insomnia in 44.62%.

Conclusions: The symptoms compatible with IBS are common among the lower socioeconomic strata leading to a negative impact on their health-related quality of life and work performance, with high rate of physician's visits and further deteriorating their economic condition. Early diagnosis and health education may improve the quality of life and productivity in this population.


Keywords


Irritable bowel syndrome, Low socio-economic, Strata prevalence

Full Text:

PDF

References


Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A etal. Irritable Bowel Syndrome: a population based study. J Gastrointestin Liver Dis. 2009;18:413-8.

Birrer RB. Irritable Bowel Syndrome. Dis- a-mon 2002;48:2.

Malagelada JR. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. Int J Clin Pract. 2006;60:157-63.

Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterol. 2006;130:1480-91.

Si JM, Wang LJ, Chen SJ, Sun LM, Ning N. Irritable bowel syndrome consulters in Zhejiang province: The symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol. 2004;10:1059-64.

Wilson S, Roberts L, Roalfe A, Bridge P, and Singh S. Prevalence of irritable bowel syndrome: a community survey. Brit J Gen Pra. 2004;54:495-502.

Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Ind J Gastroenterol. 2008;27(1):22-8.

Jr WE. 10-minute consultation, Irritable bowel syndrome. BMJ 2005;330:632.

Gwee KA, Wee S, Wong ML, Png DJ. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol. 2004;99:924-31.

Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in south China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther. 2004;19:1217-24.

Pan G, Lu S, Ke M, Han S, Guo H, Fang X. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by the cluster sampling. Chin Med J (Engl). 2000;113:35-39.

Mayer EA. Irritable Bowel Syndrome. N Engl J Med. 2008;358:1692-99.

Bergemann SM, Thielecke F, Abel E, Bergemann R. Costs of Irritable Bowel Syndrome in the UK and US. Pharmacoeconomics. 2006;24:21-37.

Spiller RC. Irritable bowel syndrome. British Medical Bulletin. 2004;72:15-29.

Hotopf M, Wilson-Jones C, Mayou R, Wadswoth M, Wessely S. Childhood predictors of adult medically unexplained hospitalizations. Brit J Psych. 2000;176:273-80.

Bergemann SM, Thielecke F, Abel E, Bergemann R. Costs of Irritable Bowel Syndrome in the UK and US. Pharmacoeconomics 2006;24:21-37.

Mayer EA. Irritable Bowel Syndrome. N Engl J Med. 2008;358:1692-99.

Graham L. ACG Releases Recommendations on the Management of Irritable Bowel Syndrome. Am Fam Phys. 2009;79:1108-17 .

Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA, et al. Clinical Determinants of Health-Related Quality of Life in Patients with Irritable Bowel Syndrome. Arch Intern Med. 2004;164:1773-80.

Hahn B A , Yan S , Strassels S . Impact of Irritable Bowel Syndrome on Quality of Life and Resource Use in the United States and United Kingdom . Digestion 1999;60:77-81.

Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterol. 2006;130:1480-91.

Chey WD, Olden K, Carter E, Boyle J, Drossman D, Chang L. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in US women. Am J Gastroenterol. 2002;97:2803-11.

Hammer T, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med. 1999;107(5A):5S-11S.

Lea R, Hopkins V, Hastleton J, Houghton LA, Whorwell PJ. Diagnostic criteria for irritable bowel syndrome: utility and applicability in clinical practice. Digestion. 2004;70:210-13.

Spiller RC. Irritable bowel syndrome. British Medical Bulletin. 2004;72:15-29.

Bolin TD. Irritable bowel syndrome. Austral Fam Phys. 2005;34:221-4.

Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Alimentary Pharmacol Therapeutics. 2005;21(11):1365-75.

Kumar BR, Dudala SR, Rao A. Kuppuswamy’s socio-economic status scale: a revision of economic parameter for 2012. Int J Res Dev Health. 2013;1:2-4.